Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2017-03-31
|
Diamyd® |
type 1 diabetes |
3 |
Diamyd Medical (Sweden) |
Autoimmune diseases - Metabolic diseases |
2017-03-31
|
mepolizumab |
hypereosinophilic syndrome |
3 |
GSK (UK) |
Inflammatory diseases - Rare diseases |
2017-03-31
|
ARGX-113 |
primary immune thrombocytopenia |
2 |
Argen-X (Belgium - The Netherlands) |
Autoimmune diseases - Hematological diseases |
2017-03-30
|
poziotinib |
non-small cell lung cancer with EGFR exon 20 insertion mutations |
2 |
Spectrum Pharmaceuticals (USA - NV) |
Cancer - Oncology |
2017-03-30
|
TAK-003 (live-attenuated tetravalent dengue vaccine candidate) |
dengue fever |
2 |
Takeda Pharmaceutical (Japan) |
Infectious diseases |
2017-03-30
|
VXM01m |
|
preclinical |
Vaximm (Germany) |
Cancer - Oncology |
2017-03-30
|
VXM04m |
|
preclinical |
Vaximm (Germany) |
Cancer - Oncology |
2017-03-30
|
VXM06 |
|
preclinical |
Vaxxim (Germany) |
Cancer - Oncology |
2017-03-30
|
ADCT-402 |
|
preclinical |
ADC Therapeutics (Switzerland) |
Cancer - Oncology |
2017-03-30
|
ADCT-502. |
|
preclinical |
ADC Therapeutics (Switzerland) |
Cancer - Oncology |
2017-03-29
|
DPX-Survivac with epacadostat (INCB24360) and low-dose cyclophosphamide |
recurrent ovarian cancer |
1b |
Immunovaccine Technologies (Canada) Incyte (USA - DE) |
Cancer - Oncology |
2017-03-28
|
CB 2679d/ISU304 |
hemophilia B |
1-2 |
Catalyst Biosciences (USA - CA) |
Rare diseases - Genetic diseases - Hematological diseases |
2017-03-28
|
VX-661 ( tezacaftor) in combination with ivacaftor |
people with cystic fibrosis ages 12 and older who have certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene |
3 |
Vertex Pharmaceuticals (USA - MA) |
Rare diseases - Genetic diseases - Lung diseases |
2017-03-27
|
NKTR-358 |
|
1 |
Nektar Therapeutics (USA - CA) |
Autoimmune diseases - Inflammatory diseases |
2017-03-27
|
NKTR-358 |
|
1 |
Nektar Therapeutics (USA - CA) |
Autoimmune diseases – Inflammatory diseases |
2017-03-27
|
combination of Diamyd® with relatively high doses of vitamin D and ibuprofen |
type 1 diabetes |
2 |
Diamyd Medical (Sweden) |
Autoimmune diseases - Metabolical diseases |
2017-03-27
|
remimazolam |
procedural sedation in patients undergoing colonoscopy |
3 |
Paion (Germany) |
CNS diseases |
2017-03-27
|
sarecycline |
acne |
3 |
Allergan (Ireland) Paratek Pharmaceuticals (USA - MA) |
Dermatological diseases |
2017-03-25
|
evenamide (NW-3509) |
schizophrenia |
2 |
Newron Pharmaceuticals (Italy) |
CNS diseases - Mental diseases |
2017-03-23
|
ADC-1013 |
advanced solid tumors |
1 |
Alligator Bioscience (Sweden) |
Cancer - Oncology |